Denali Therapeutics Inc (DNLI): Eigentümerstruktur
Der letzte verfügbare Schlusskurs ist 03.09.2026. Die angezeigten Informationen beziehen sich auf den historischen Stand und sind nicht tagesaktuell.
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 35,75 US Dollar | 15 | 4 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 159.847.403 | 11,85 | 10,78 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Denali Therapeutics Inc
Mitarbeiter 503
Handelsplatz NASDAQ
Ticker Symbol DNLI
IPO Datum 2017-12-08
Adresse 161 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
Webseite https://www.denalitherapeutics.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Ryan J. Watts Ph.D. | Co-Founder, President, CEO & Director |
| 2 | Dr. Alexander O. Schuth M.D., Ph.D. | Co-Founder, CFO, COO & Secretary |
| 3 | Dr. Dana Andersen | Chief Technical and Manufacturing Officer |
| 4 | Mr. Joe Lewcock Ph.D. | Chief Scientific Officer |
| 5 | Mr. Chris Walsh J.D. | General Counsel |
| 6 | Ms. Cindy Dunkle | Chief People Officer |
| 7 | Ms. Katie Peng M.B.A. | Chief Commercial Officer |
| 8 | Mr. Peter Chin M.D. | Acting Chief Medical Officer & Head of Development |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | BlackRock Inc | 8,15% | 0,30 Mrd. USD |
| 2 | Baillie Gifford & Co Limited. | 7,48% | 0,27 Mrd. USD |
| 3 | T. Rowe Price Investment Management,Inc. | 5,33% | 0,19 Mrd. USD |
| 4 | Temasek Holdings Ltd. | 4,39% | 0,16 Mrd. USD |
| 5 | State Street Corp | 3,92% | 0,14 Mrd. USD |
| 6 | Vanguard Capital Management, LLC | 3,85% | 0,14 Mrd. USD |
| 7 | Vanguard Portfolio Management, LLC | 3,83% | 0,14 Mrd. USD |
| 8 | FMR Inc | 2,86% | 0,10 Mrd. USD |
| 9 | UBS Asset Mgmt Americas Inc | 2,77% | 0,10 Mrd. USD |
| 10 | The Goldman Sachs Group Inc | 2,76% | 0,10 Mrd. USD |
| 11 | Baker Bros Advisors LP | 2,33% | 0,09 Mrd. USD |
| 12 | Geode Capital Management, LLC | 2,33% | 0,09 Mrd. USD |
| 13 | Holocene Advisors, LP | 2,00% | 0,07 Mrd. USD |
| 14 | AllianceBernstein L.P. | 1,81% | 0,07 Mrd. USD |
| 15 | Dimensional Fund Advisors, Inc. | 1,79% | 0,07 Mrd. USD |
| 16 | NORGES BANK | 1,77% | 0,06 Mrd. USD |
| 17 | Pictet Asset Manangement SA | 1,75% | 0,06 Mrd. USD |
| 18 | UBS Group AG | 1,61% | 0,06 Mrd. USD |
| 19 | Capital Research Global Investors | 1,61% | 0,06 Mrd. USD |
| 20 | T. Rowe Price Associates, Inc. | 1,54% | 0,06 Mrd. USD |